ANI PHARMACEUTICALS INC 4

President & CEO Nikhil Lalwani sold 5,400 shares of ANI Pharmaceuticals, Inc. common stock at an average price of $74.30 on August 25, 2026 under a Rule 10b5-1 plan.

On August 25, 2026, ANI Pharmaceuticals, Inc. President and CEO Nikhil Lalwani sold 5,400 shares of the company’s common stock at a weighted average price of $74.30 per share, for proceeds of approximately $401,220. The transaction was executed under a pre-established Rule 10b5-1 trading plan, with individual sale prices ranging from $73.58 to $74.61. Following this sale, Lalwani continued to hold 344,489 shares of ANI Pharmaceuticals common stock in direct ownership, indicating that the transaction represented a relatively small portion of his overall equity stake in the company.

Filing Facts

CIK

1023024

Ticker

ANIP

Form

4

Source Type

fda

Accession

0001822629-26-000014

Alert Tier

6